139 related articles for article (PubMed ID: 10582394)
1. [Effects of tibolone on lipid and glucose metabolism as well as insulin secretion in postmenopausal women].
Villanueva LA; Ortega R; Morimoto S; Villanueva S; Arranz C
Ginecol Obstet Mex; 1999 Oct; 67():473-7. PubMed ID: 10582394
[TBL] [Abstract][Full Text] [Related]
2. Metabolic effects of tibolone in postmenopausal women with non-insulin dependent diabetes mellitus.
Prelevic GM; Beljic T; Balint-Peric L; Ginsburg J
Maturitas; 1998 Jan; 28(3):271-6. PubMed ID: 9571604
[TBL] [Abstract][Full Text] [Related]
3. Two-year prospective and comparative study on the effects of tibolone on lipid pattern, behavior of apolipoproteins AI and B.
Castelo-Branco C; Casals E; Figueras F; Sanjuan A; Vicente JJ; Balasch J; Vanrell JA
Menopause; 1999; 6(2):92-7. PubMed ID: 10374214
[TBL] [Abstract][Full Text] [Related]
4. Effect of tibolone on glucose and lipid metabolism in postmenopausal women.
Cagnacci A; Mallus E; Tuveri F; Cirillo R; Setteneri AM; Melis GB
J Clin Endocrinol Metab; 1997 Jan; 82(1):251-3. PubMed ID: 8989269
[TBL] [Abstract][Full Text] [Related]
5. Tibolone and the serum lipid/lipoprotein profile: does this have a role in cardiovascular protection in postmenopausal women?
Ginsburg J; Prelevic GM
Menopause; 1999; 6(2):87-9. PubMed ID: 10374212
[No Abstract] [Full Text] [Related]
6. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women.
Laan E; van Lunsen RH; Everaerd W
Climacteric; 2001 Mar; 4(1):28-41. PubMed ID: 11379375
[TBL] [Abstract][Full Text] [Related]
7. Tibolone and its effects on bone: a review.
Berning B; Bennink HJ; Fauser BC
Climacteric; 2001 Jun; 4(2):120-36. PubMed ID: 11428176
[TBL] [Abstract][Full Text] [Related]
8. Tibolone exerts its protective effect on trabecular bone loss through the estrogen receptor.
Ederveen AG; Kloosterboer HJ
J Bone Miner Res; 2001 Sep; 16(9):1651-7. PubMed ID: 11547834
[TBL] [Abstract][Full Text] [Related]
9. Effects of tibolone and cyclic hormone replacement therapy on glucose metabolism in non-diabetic obese postmenopausal women: a randomized study.
Morin-Papunen LC; Vauhkonen I; Ruokonen A; Tapanainen JS; Raudaskoski T
Eur J Endocrinol; 2004 May; 150(5):705-14. PubMed ID: 15132728
[TBL] [Abstract][Full Text] [Related]
10. [Effect of hormone replacement with tibolone on plasma insulin and blood glucose in postmenopause].
Saucedo RP; Basurto L; Fonseca E; Zárate A
Ginecol Obstet Mex; 2001 Aug; 69():301-3. PubMed ID: 11599314
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
Hudita D; Posea C; Ceausu I; Rusu M
Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586
[TBL] [Abstract][Full Text] [Related]
12. Regression of endometrial thickness in combination with reduced withdrawal bleeding as a progestational effect of tibolone in postmenopausal women on oestrogen replacement therapy.
Meuwissen JH; Wiegerinck MA; Haverkorn MJ
Maturitas; 1995 Feb; 21(2):121-5. PubMed ID: 7752949
[TBL] [Abstract][Full Text] [Related]
13. Effects of tibolone or continuous combined oestradiol/norethisterone acetate on glucose and insulin metabolism.
Manassiev N; Godsland IF; Proudler AJ; Whitehead MI; Stevenson JC
Clin Endocrinol (Oxf); 2013 Feb; 78(2):297-302. PubMed ID: 22775481
[TBL] [Abstract][Full Text] [Related]
14. [Basic principles of hormone replacement therapy in the postmenopause].
Dören M
Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
[TBL] [Abstract][Full Text] [Related]
15. Effects of menopause and postmenopausal tibolone treatment on plasma TNFalpha, IL-4, IL-10, IL-12 cytokine pattern and some bone turnover markers.
Vural P; Canbaz M; Akgul C
Pharmacol Res; 2006 Apr; 53(4):367-71. PubMed ID: 16503406
[TBL] [Abstract][Full Text] [Related]
16. Postmenopausal tibolone therapy: biologic principles and applied clinical practice.
Notelovitz M
MedGenMed; 2007 Jan; 9(1):2. PubMed ID: 17435612
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma of the endometrium in patients treated with tibolone.
Yazigi R; Sahid S; Contreras L; Rodriguez T
Gynecol Oncol; 2004 May; 93(2):568-70. PubMed ID: 15099984
[TBL] [Abstract][Full Text] [Related]
18. Tibolone does not have a sustained measurable thermogenic effect in postmenopausal women.
Aktan E; Kaleli B; Alataş E
Acta Obstet Gynecol Scand; 1998 Apr; 77(4):433-4. PubMed ID: 9598953
[TBL] [Abstract][Full Text] [Related]
19. Effects of tibolone on serum lipoprotein and apolipoprotein levels compared with a cyclical estrogen/progestogen regimen.
Farish E; Barnes JF; Fletcher CD; Ekevall K; Calder A; Hart DM
Menopause; 1999; 6(2):98-104. PubMed ID: 10374215
[TBL] [Abstract][Full Text] [Related]
20. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone.
Lippuner K; Haenggi W; Birkhaeuser MH; Casez JP; Jaeger P
J Bone Miner Res; 1997 May; 12(5):806-12. PubMed ID: 9144347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
